Nayak Asha 4
4 · Sage Therapeutics, Inc. · Filed Nov 8, 2017
Insider Transaction Report
Form 4
Nayak Asha
Director
Transactions
- Award
Stock Options (Right to buy)
2017-11-06+20,883→ 20,883 totalExercise: $65.49Exp: 2027-11-06→ Common Stock (20,883 underlying)
Footnotes (1)
- [F1]All of the shares subject to the option vest monthly measured from November 6, 2017 (the "Grant Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the Third anniversary of the Grant Date, subject to continued service through such date.